ScholarLens Back to search
2007•Unpublished venueOpen access

Patent Rights and Access to Medicines: Are Patents Really the Only Barrier for Good Health Care in Developing Countries?

Björn Ley

Open full text 1 citations

Abstract

The scope of this chapter is threefold: The first is the analysis of problems arising with the adoption of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement between access to medicine on the one side and the patent owner's rights on the other side. The second is the availability of alternatives for an international patent system and whether these solutions more adequately meet the needs of developing countries. The third one is a cursory examination of other restraints which impede the provision of health care in developing countries. Prior to the TRIPS Agreement, the Paris Convention for the Protection of Industrial Property governed international patent relations.Keywords: access to medicine; health care infrastructure; patent rights; TRIPS agreement

Open-access reader

About this research paper

What this paper is about

The scope of this chapter is threefold: The first is the analysis of problems arising with the adoption of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement between access to medicine on the one side and the patent owner's rights on the other side. The second is the availability of alternatives for an international patent system and whether these solutions more adequately meet the needs of developing countries. The third one is a cursory examination of other restraints which impede the provision of health care in developing countries. Prior to the TRIPS Agreement, the Paris Convention for the Protection of Industrial Property governed international patent relations.Keywords: access to medicine; health care infrastructure; patent rights; TRIPS agreement

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The scope of this chapter is threefold: The first is the analysis of problems arising with the adoption of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement between access to medicine on the one side and the patent owner's rights on the other side. The second is the availability of alternatives for an international patent system and whether these solutions more adequately meet the needs of developing countries. The third one is a cursory examination of other restraints which impede the provision of health care in developing countries. Prior to the TRIPS Agreement, the Paris Convention for the Protection of Industrial Property governed international patent relations.Keywords: access to medicine; health care infrastructure; patent rights; TRIPS agreement

Key concepts: TRIPS architecture, Intellectual property, TRIPS Agreement, Scope (computer science), Convention, Developing country, Access to medicines, Business

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Patent Rights and Access to Medicines: Are Patents Really the Only Barrier for Good Health Care in Developing Countries? — Research Paper | ScholarLens